At Dynavax we are proud of work we do. Through our expertise in TLR biology we have designed compounds that stimulate multiple innate mechanisms of tumor and development of immune memory associated with tumor-specific antigens.
http://www.dynavax.com/
TODAY'S RATING
#608,658
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.4 seconds
Dynavax Technologies
2929 ●●●●●treet
Ber●●●ley , CA, 94710
US
View this contact
Dynavax Technologies
Technologies, Dynavax
2929 ●●●●●treet
Ber●●●ley , CA, 94710
US
View this contact
Dynavax Technologies
Technologies, Dynavax
2929 ●●●●●treet
Ber●●●ley , CA, 94710
US
View this contact
BUY YOUR DOMAIN
28
YEARS
2
MONTHS
27
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
107
SITE IP
173.203.62.111
LOAD TIME
1.391 sec
SCORE
6.2
Dynavax | Home | dynavax.com Reviews
https://dynavax.com
At Dynavax we are proud of work we do. Through our expertise in TLR biology we have designed compounds that stimulate multiple innate mechanisms of tumor and development of immune memory associated with tumor-specific antigens.
Investor Relations | Dynavax Technologies Corporation
Skip to main navigation. More information is coming soon. More events are coming soon. All events and presentations. Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination with KEYTRUDA for Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting. Dynavax Reports Fourth Quarter and Year End 2017 Financial Results. Dynavax to Present at the Cowen and Co. Annual Health Care Conference. E-Delivery of Stockholder Communications. Phase 1b/2, Open-Label, Mul...
dynavax.com
Dynavax | Our Pipeline
http://www.dynavax.com/our-pipeline
Developing immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology. Melanoma / Head and Neck Squamous Cell Carcinoma. IL-10 study conducted by Merck and Co.
Dynavax Technologies :: DV281
http://www.dynavax.com/our-pipeline/cancer-immunotherapy/dv281
Dynavax pioneered the development of an inhaled TLR9 agonist for asthma. This oligonucleotide, AZD1419, was developed in partnership with AstraZeneca and is currently being evaluated in a phase 2 clinical trial in asthma patients. Based on this experience, Dynavax is developing a novel TLR9 agonist, DV281, formulated for delivery to lung cancer patients as an inhaled aerosol.
Dynavax | Toll-like Receptors
http://www.dynavax.com/our-science/toll-receptors
Dynavax Technologies :: Preclinical
http://www.dynavax.com/our-pipeline/cancer-immunotherapy/preclinical
Dynavax | About Us
http://www.dynavax.com/about-us
We are committed to utilizing the immune system to prevent and fight disease. Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. We develop immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology and its ability to modulate the immune system. SD-101 - Cancer Immunotherapy.
TOTAL PAGES IN THIS WEBSITE
18
Ondernemen met Passie en Stijl: Dynavax to Acquire Rhein Biotech GmbH From Crucell
http://ksiron.blogspot.com/2006/03/dynavax-to-acquire-rhein-biotech-gmbh.html
Ondernemen met Passie en Stijl. Dynavax to Acquire Rhein Biotech GmbH From Crucell. Dynavax Gains Ownership of GMP Vaccine Manufacturing Facility, Vaccine Pipeline and HEPLISAV Commercialization Rights. BERKELEY, Calif., March 27 /PRNewswire-FirstCall/ - Dynavax Technologies Corporation ( NASDAQ:DVAX. Financial Terms of the Transaction. The transaction is anticipated to close in the second quarter of 2006. Pacific Growth Equities LLC served as advisor to Dynavax in this transaction. Dynavax will hold a c...
Team | Genomics Institute
https://ucscgenomics.soe.ucsc.edu/team
Faculty & Research Investigators. Graduate Students & Post-Docs. Admin & Operations. Faculty and Research Investigators. Graduate Students and Post-Docs. David’s titles include:. Howard Hughes Medical Institute. A web-based tool that is used extensively in biomedical research. He co-founded the Genome 10K Project. So science can learn from other vertebrate genomes, co-founded the Treehouse Childhood Cancer Project. Director, Treehouse Childhood Cancer Initiative. Director, Research and Development. Jim K...
Dynavax Technologies Corporation :: Investor Relations
http://investors.dynavax.com/index.cfm
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Companys lead product candidate is HEPLISAV, an investigational adult hepatitis B vaccine. For more information visit www.dynavax.com. Annual William Blair Growth Stock Conference. UBS Global Healthcare Conference. Dynavax Presentations from American Association for Cancer Research 2016 Conference. All events and presentations ».
bioeng-symposium-2015.soe.ucsc.edu
Sponsors | 16th Annual UC Systemwide Bioengineering Symposium
https://bioeng-symposium-2015.soe.ucsc.edu/sponsors
Skip to main content. UC Systemwide Bioengineering Symposium. Monday, June 22. Tuesday, June 23. Wednesday, June 24. Human Genome Anniversary Toast. Information about becoming a sponsor. Sr Director of Corporate Development, Baskin School of Engineering, UC Santa Cruz. Director of Development, UC Santa Cruz Genomics Institute. University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95064. Privacy Policy and Terms of Use.
bioeng-symposium-2015.soe.ucsc.edu
Shark Tank | 16th Annual UC Systemwide Bioengineering Symposium
https://bioeng-symposium-2015.soe.ucsc.edu/sharktank
Skip to main content. UC Systemwide Bioengineering Symposium. Monday, June 22. Tuesday, June 23. Wednesday, June 24. Human Genome Anniversary Toast. Monday, June 22, 2015. 12:15 1:45 pm (during lunch). Invited participants with bioengineering start-up ideas will pitch their concepts to a panel of faculty and corporate volunteers who challenge those concepts and award prizes to the best ones. Monday, June 22. Tuesday, June 23. Wednesday, June 24. Human Genome Anniversary Toast.
Exited Investments - HealthCap
http://www.healthcap.eu/the-investments/exited-investments
Senior and Special Advisors. The first five funds have financed 91 companies. Approximately 30 of the companies were startups and several have successfully completed their Initial Public Offerings. HealthCap I, II, III, IV and V are now fully invested. The most recent fund, HealthCap VI, was established in the spring of 2011. HealthCap VI is currently actively pursuing new investment opportunities. Acquired by Nektar in 2005). Acquired by Investor in 2014). Acquired by Bayer in 2014). Is developing Ersat...
Dynavax Technologies Corporation :: Annuals and Proxies
http://investors.dynavax.com/annuals-proxies.cfm
File is in Briefcase. File is in Briefcase. Add file to Briefcase.
Dynavax Technologies Corporation :: Press Releases
http://investors.dynavax.com/releases.cfm
Aug 5, 2016. Dynavax Reports Second Quarter 2016 Financial Results. BERKELEY, CA - (Marketwired) - 08/05/16 - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the second quarter and six months ended June 30, 2016. The Company had $139.0 million in cash, cash equivalents and marketable securities as of June 30, 2016, compared to $196.1 million at December 31, 2015. Th. File is in Briefcase. Aug 5, 2016. File is in Briefcase. Jun 11, 2016. File is in Briefcase. BERKELEY,...
TOTAL LINKS TO THIS WEBSITE
107
Dynavate
Find the best information and most relevant links on all topics related to dynavate.com.
Dynavation
Find the best information and most relevant links on all topics related to dynavation.com.
Dynavations Technology Group
Bending Computers to Your Will. Computers do our bidding. And that they should. Nobody knows better than us, that this is true. We're always coming up with great ways to make our clients computers work for them - to do exactly what they need them to do, without fail. We are about special projects. That's what we do. If you have a project that needs professional and reliable results, we can help. Find out how with a free consultation. Technical services provided by CompuDude. Custom scripts and automation.
Dynavativ | We grow with your growth
We grow with your growth to bring the Dynamic And Innovation out for you. Strive to deliver real results to businesses by offering a consulting-led integrated portfolio of IT and IT-enabled services according to the best ITSM standards. We work with clients on-site to ensure requirements understanding and keep client informed about the progress of the projects to avoid any last minutes disclosures. Maiti Nepal www.maitinepal.com. BM Foundation www.bmfoundation.org.np. Our consulting expertise combined wi...
Dynavax | Home
Experts in TLR Biology. We are developing immunotherapies based on cutting-edge Toll-like receptor (TLR) biology and its ability to modulate the immune system. Learn More. Through our expertise in TLR biology we are developing compounds designed to stimulate multiple innate mechanisms of tumor killing and development of immune memory associated with tumor-specific antigens. Learn More. Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update.
Rhein Biotech GmbH
Rhein Biotech GmbH
Dynave Oy
Dynave Oy on vuonna 2008 perustettu pieni IT-alan yritys, joka tarjoaa mm. ohjelmistotuotanto- ja konsultointipalveluita vankalla kokemuspohjalla. Yritys toimii enimmäkseen Oulun alueella. Päätoimintana on ohjelmistokehitys, mutta yritys tekee myös mm. kaapelointitöitä, palvelinasennuksia, vianselvitystä ja datan pelastustöitä mm. kiintolevyrikon sattuessa. NET: C#, VB.NET. C /Qt (Windows, Mac). C (palvelimet, sulautetut Linux-reitittimet). Verkot, alustat, tietokannat ym.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@dynavec.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
